Tonix Pharmaceuticals Holding Corp - ESG Rating & Company Profile powered by AI
The article includes a questions and answers section on Tonix Pharmaceuticals Holding Corp. This Sustainability rating for Tonix Pharmaceuticals Holding Corp represents the company's reporting of the UN SDGs. Other corporations in the rating industry group for Tonix Pharmaceuticals Holding Corp are displayedin the table.
Tonix Pharmaceuticals Holding Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.7; made up of an environmental score of 2.7, social score of 6.4 and governance score of 8.0.
5.7
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 541 | Wntresearch AB | 5.8 | High |
| 541 | Zenotech Laboratories Ltd | 5.8 | High |
| 579 | Tonix Pharmaceuticals Holding Corp | 5.7 | High |
| 579 | Caplin Point Laboratories Ltd | 5.7 | High |
| 579 | Biotest AG | 5.7 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Tonix Pharmaceuticals Holding Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp report the average age of the workforce?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose cybersecurity risks?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp offer flexible work?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp conduct supply chain audits?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose water use targets?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid Tonix Pharmaceuticals Holding Corp have a product recall in the last two years?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose incidents of discrimination?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Tonix Pharmaceuticals Holding Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose parental leave metrics?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Tonix Pharmaceuticals Holding Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose its waste policy?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp report according to TCFD requirements?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose energy use targets?
Sign up for free to unlockDoes Tonix Pharmaceuticals Holding Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Tonix Pharmaceuticals Holding Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Tonix Pharmaceuticals Holding Corp
These potential risks are based on the size, segment and geographies of the company.
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer, including TNX-1500, a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. Its rare disease portfolio comprises TNX-2900 for the treatment of Prader-Willi syndrome. The company's infectious disease pipeline includes TNX-801, a vaccine to prevent smallpox and monkeypox; TNX-1840 and TNX-1850 that are live virus vaccines based on its recombinant pox vaccine (RPV) platform for COVID-19; TNX-3500, a small molecule antiviral drug to treat acute COVID-19; and TNX-102 SL, a small molecule drug to treat Long COVID, a chronic post-acute COVID-19 condition. Its CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions, including TNX-102 SL, which is in mid-Phase 3 development for the management of fibromyalgia; TNX-1900 that is in development for the prevention of migraine headache; and TNX-1300, a biologic designed to treat cocaine intoxication. The company was founded in 2007 and is headquartered in Chatham, New Jersey.